October19, 2010 - PMI Labs Signs First Partnership Deal in the Middle East [HTML]
PMI Labs is excited to announce that it has signed its first Middle Eastern technology partnership deal with Al Mokhtabar Laboratories in Egypt.
October 14, 2010 - PMI Labs Completes Redesign of the Next Generation ClearCyte™ [HTML]
PMI Labs is excited to announce the completion of its next generation ClearCyte™ quantitative cytology platform.
During the past 3 years the Company’s scientific and engineering team has redesigned and reengineered the ClearCyte™ platform to meet more stringent processing and standardization performance measures. As a result of the redesign efforts, per-slide scanning time of the machine has been reduced by more than 65%. This delivers a yearly scanning capacity for each platform of over 40,000 samples.
November 10, 2009 -PMI Labs Saddened by Loss of Board Member and Great Citizen, Dr. Donald Rix [HTML]
Vancouver, Canada (November 10, 2009) –
Dr. Donald Rix, Perceptronix Medical Inc. (“PMI Labs”) Board member and investor, passed away on Friday November 6th, 2009 at the age of 78 following a long illness. He was a truly great citizen of Canada, renowned for his support of the biotechnology industry and for his philanthropy in health, education and the arts.
August 18 , 2009 - PMI Labs Signs LungSign™ Agreement with University of Chile for Regional Lung Cancer Screening Program [HTML]
Vancouver, Canada (August 18, 2009) –PMI Labs (Perceptronix Medical Inc. Laboratories) and University of Chile Faculty of Medicine announce the signing of an agreement focused on implementing PMI Labs’ proprietary quantitative cytology approach of analyzing sputum specimens to complement a lung cancer screening program for high risk individuals in Santiago and in the northern part of Chile (Metropolitan and Antofagasta Regions).
July 27, 2009 - PMI Columbia Labs Signs LungSign™ Agreement with Hong Kong Sanatorium & Hospital for Lung Cancer Screening Program [HTML]
Vancouver, Canada (July 27, 2009) – Perceptronix Medical Inc. Laboratories (PMI Labs) and Hong Kong Sanatorium & Hospital (HKSH), one of the largest private hospitals in Hong Kong, announce the signing of an agreement focused on implementing PMI Labs’ proprietary quantitative cytology approach of analyzing sputum specimens to complement the lung cancer screening program offered by HKSH.
June 4, 2008 - CTV News - British Columbia
"New lung cancer screening test now in Canada" - featured by CTV British Columbia's Dr. Rhonda Low.
September 27, 2008 - Medical Acoustics LLC
"Medical Acoustics Reports Initial Commercial Shipments of Revolutionary Lung Flute."
"Perceptronix Medical Inc. to Incorporate Lung Flute (R) into its lung cancer diagnostic test, LungSign (TM)"
May 30, 2008 - Coventry - Midland Newspapers
"Life-saver cancer test launched - Thousands of people in Coventry could get early lung cancer detection, thanks to a pioneering move by the city's superhospital."
November 14 - 20, 2006 - Business in Vancouver - by Daniela Tuchel [PDF]
"Private Matters - New Perceptronix CEO
Carl Roy has jumped from
the public sector into
private enterprise to help
the Vancouver biotech fight
cancer and turn a profit in the bargain."
CTV News
CTV News recently featured ClearSign™ buccal in "Your Health with
Dr. Rhonda Low."
April 19 - 25, 2005 - Business in Vancouver- by Glenn Drexhage [PDF]
"Vancouver biotechs take aim at lung cancer. Perceptronix Medical Inc. and Protox Therapeutics Inc. look to China and licensing opportunities for their products in the fight against the deadly disease."
Perceptronix provides accredited journalists with the assistance they need to develop coverage quickly and accurately. We are pleased to coordinate interviews with members of the executive team, to help secure other materials that may assist reporting, and to help fact check information.
For information, please contact:
Perceptronix
Suite 400 - 555 West 8th Avenue
Vancouver, BC
Canada, V5Z 1C6
Tel: 604.629.8785
Fax: 604.629.8786
Email: info@perceptronix.com
|
TOP
Publications